These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 769955)

  • 1. Evaluation of CCNU (NSC-79037) used for the prevention of CNS involvement in Burkitt's lymphoma.
    Ziegler JL; Magrath IT; Nkrumah FK; Perkins IV; Simon R
    Cancer Chemother Rep; 1975; 59(6):1155-6. PubMed ID: 769955
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of Burkitt's lymphoma involving the central nervous system.
    Ziegler JL; Magrath IT; Bluming AZ
    Afr J Med Med Sci; 1976 Jun; 5(2):121-4. PubMed ID: 829717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burkitt's lymphoma--a model for intensive chemotherapy.
    Ziegler JL; Deisseroth AB; Applebaum FR; Graw RG
    Semin Oncol; 1977 Sep; 4(3):317-23. PubMed ID: 335519
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of metastatic testicular carcinoma with bleomycin (NSC-125066) used alone or in combination with CCNU (NSC-79037).
    Sonntag RW; Brunner KW; Batz K; Ryssel HJ
    Cancer Chemother Rep; 1975; 59(2 Pt 1):429-31. PubMed ID: 50125
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy of Burkitt's lymphoma.
    Ziegler JL
    Cancer; 1972 Dec; 30(6):1534-40. PubMed ID: 4641762
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary report on the use of CCNU (NSC-79037), adriamycin (NSC-123127), and hexamethylmelamine (NSC-13875) in carcinoma of the lung.
    Wilson WL; Andrews NC; Frelick RW; Nealon TF; Bick RL; Adams T
    Cancer Treat Rep; 1976 Mar; 60(3):269-71. PubMed ID: 816467
    [No Abstract]   [Full Text] [Related]  

  • 7. A clinical trial of CCNU (1-(2 chloroethyl)-3-cyclohexyl-1-nitrosourea) (NSC 79037) in advanced ovarian carcinoma.
    Sasaki TM; McConnell DB; Moseley HS; Merhoff GC; Fletcher WS
    J Surg Oncol; 1975; 7(5):347-50. PubMed ID: 1100915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma--final evaluation. E.O.R.T.C. Brain Tumor Group.
    Eur J Cancer (1965); 1978 Aug; 14(8):851-6. PubMed ID: 357162
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination chemotherapy with CCNU (NSC-79037) and 5-(3, 3-bis(2-chloroethyl)-1-triazeno)-imidazole-4-carboxamide (NSC-82196).
    Chang H; Freireich EJ; Khaliq A; Einhorn L; Gottlieb JA
    Cancer Chemother Rep; 1975; 59(4):769-71. PubMed ID: 1100230
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of CCNU on survival, rate of objective remission and duration of free interval in patients with malignant brain glioma--first evaluation.
    Eur J Cancer (1965); 1976 Jan; 12(1):41-5. PubMed ID: 1269526
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trials with procarbazine (NSC-77213), streptozotocin (NSC-85998), 6-THIOGUANINE (NSC-752), and CCNU (NSC-79037) in patients with metastatic cancer of the large bowel.
    Horton J; Mittelman A; Taylor SG; Jurkowitz L; Bennett JM; Ezdinli E; Colsky J; Hanley JA
    Cancer Chemother Rep; 1975; 59(2 Pt 1):333-40. PubMed ID: 125147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DTIC (NSC-45388) in malignant melanoma: a perspective.
    Comis RL
    Cancer Treat Rep; 1976 Feb; 60(2):165-76. PubMed ID: 769969
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination chemotherapy with CCNU (NSC-79037),hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in advanced bronchogenic carcinoma.
    DiBella NJ; Nelson RA; Norgard MJ
    Oncology; 1975; 32(2):82-5. PubMed ID: 815858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of radiotherapy alone with radiotherapy and CCNU in cerebral glioma.
    Garrett MJ; Hughes HJ; Freedman LS
    Clin Oncol; 1978 Mar; 4(1):71-6. PubMed ID: 346276
    [No Abstract]   [Full Text] [Related]  

  • 15. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy.
    Cedermark BJ; Didolkar MS; Elias EG
    Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of methyl-CCNU and CCNU in patients with advanced forms of Hodgkin's disease, lymphosarcoma nad reticulum cell sarcoma.
    Maurice P; Glidewell O; Jacquillat C; Silver RT; Carey R; Pas AT; Cornell CJ; Burningham RA; Nissen NI; Holland JF
    Cancer; 1978 May; 41(5):1658-63. PubMed ID: 348294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of solid tumors and lymphomas with methyl-CCNU (NSC-95441): a phase II study.
    Firat D; Tekuzman G
    Cancer Chemother Rep; 1975; 59(5):1021-3. PubMed ID: 1106843
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechlorethamine (NSC-762) plus CCNU (NSC-79037) in the treatment of inoperable squamous and large cell carcinoma of the lung.
    Edmonson JH; Lagakos S; Stolbach L; Perlia CP; Bennett JM; Mansour EG; Horton J; Regelson W; Cummings FJ; Israel L; Brodsky I; Shnider BI; Creech R; Carbone PP
    Cancer Treat Rep; 1976 May; 60(5):625-7. PubMed ID: 186183
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II study of methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
    Engstrom PF; Catalano RB; Creech RH
    Cancer Treat Rep; 1976 Mar; 60(3):285-7. PubMed ID: 1260784
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva.
    Omura GA; Shingleton HM; Creasman WT; Blessing JA; Boronow RC
    Cancer Treat Rep; 1978 May; 62(5):833-5. PubMed ID: 350400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.